Evidence map›Paper›PMID 22523591›Full record

ArticlePloS one2012

Risk factors and characterization of Plasmodium vivax-associated admissions to pediatric intensive care units in the Brazilian Amazon.

Ellen Fátima Caetano Lança, Belisa Maria Lopes Magalhães, Sheila Vitor-Silva, André Machado Siqueira, Silvana Gomes Benzecry, Márcia Almeida Araújo Alexandre, Connor O'Brien, Quique Bassat, Marcus Vinícius Guimarães Lacerda

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 4 pooled it
11.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 4 syntheses or guidelines pooled it, 73 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Respiratory Complications ofThe American journal of tropical medicine and hygiene · 2017
    Pooled it
  4. Pooled it
  5. Article
  6. Review
  7. Review
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Frontiers in cellular and infection microbiology · 2018
    Review
  15. Article
  16. Article
  17. Global Epidemiology of Plasmodium vivax.The American journal of tropical medicine and hygiene · 2016
    Review
  18. Article
  19. Management of relapsing Plasmodium vivax malaria.Expert review of anti-infective therapy · 2016
    Review
  20. Cardiovascular changes in patients with non-severeInternational journal of cardiology. Heart & vasculature · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Ellen Fátima Caetano LançaUniversidade do Estado do Amazonas, Manaus, Amazonas, Brazil.
Belisa Maria Lopes Magalhães
Sheila Vitor-Silva
André Machado Siqueira
Silvana Gomes Benzecry
Márcia Almeida Araújo Alexandre
Connor O'Brien
Quique Bassat
Marcus Vinícius Guimarães Lacerda
Universidade do Estado do Amazonas · BRFundação de Medicina Tropical · BRColumbia University Irving Medical Center · USUniversidade Federal do Amazonas · BRUniversitat de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPlasmodium vivax is responsible for a significant proportion of malaria cases worldwide and is increasingly reported as a cause of severe disease. The objective of this study was to characterize severe vivax disease among children hospitalized in intensive care units (ICUs) in the Western Brazilian Amazon, and to identify risk factors associated with disease severity. METHODS AND

findingsIn this retrospective study, clinical records of 34 children, 0-14 years of age hospitalized in the 11 public pediatric and neonatal ICUs of the Manaus area, were reviewed. P. falciparum monoinfection or P. falciparum/P. vivax mixed infection was diagnosed by microscopy in 10 cases, while P. vivax monoinfection was confirmed in the remaining 24 cases. Two of the 24 patients with P. vivax monoinfection died. Respiratory distress, shock and severe anemia were the most frequent complications associated with P. vivax infection. Ninety-one children hospitalized with P. vivax monoinfections but not requiring ICU were consecutively recruited in a tertiary care hospital for infectious diseases to serve as a reference population (comparators). Male sex (p = 0.039), age less than five years (p = 0.028), parasitemia greater than 500/mm(3) (p = 0.018), and the presence of any acute (p = 0.023) or chronic (p = 0.017) co-morbidity were independently associated with ICU admission. At least one of the WHO severity criteria for malaria (formerly validated for P. falciparum) was present in 23/24 (95.8%) of the patients admitted to the ICU and in 17/91 (18.7%) of controls, making these criteria a good predictor of ICU admission (p = 0.001). The only investigated criterion not associated with ICU admission was hyperbilirubinemia (p = 0.513)].

conclusionsOur study points to the importance of P. vivax-associated severe disease in children, causing 72.5% of the malaria admissions to pediatric ICUs. WHO severity criteria demonstrated good sensitivity in predicting severe P. vivax infection in this small case series.

Indexed as

AdolescentBrazilChildChild, PreschoolCoinfectionFemaleHospitalizationHumansInfantIntensive Care Units, PediatricMalaria, FalciparumMalaria, VivaxMaleParasitemiaPlasmodium vivaxRetrospective Studies

Identifiers

PMID22523591
PMCPMC3327677
OpenAlexW2050115139

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.